Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 73 | ECE2021 | Next issue

European Congress of Endocrinology 2021

Online
22 May 2021 - 26 May 2021

Card image cap
The European Congress of Endocrinology provides a global platform for the international endocrine community to discuss the latest advances in the field.

Oral Communications

Oral Communications 1: Adrenal and Cardiovascular Endocrinology

ea0073oc1.1 | Oral Communications 1: Adrenal and Cardiovascular Endocrinology | ECE2021

Risk of developing autonomous cortisol secretion and/or significant tumor growth in non-functioning adrenal incidentalomas during follow-up

Araujo Castro Marta , Lázaro Cristina Robles , Ramírez Paola Parra , García Centeno Rogelio , Gracia Gimeno Paola , Tome Mariana , Antonio Sampedro Núñez Miguel , Marazuela Mónica , Escobar-Morreale Héctor F. , Valderrábano Herrero Pablo

PurposeTo assess the risk of developing hypercortisolism and/or tumor growth in non-functioning adrenal incidentalomas (NFAIs) during follow-up.MethodsSeven Spanish institutions participated in this retrospective study for patients with AIs. 1097 patients with one or more AIs ≥ 1 cm evaluated by participating physicians between 2013 and 2020 were subject to inclusion. Patients with missing values in the...

ea0073oc1.2 | Oral Communications 1: Adrenal and Cardiovascular Endocrinology | ECE2021

YAP/TAZ signaling is involved in the regulation of adrenocortical progenitors in stress

Berger Ilona , Santambrogio Alice , Bornstein Stefan , Andoniadou Cynthia L. , Charlotte Steenblock

A tightly regulated stress system is pivotal for health and the adrenal cortex is a master regulator of the endocrine stress response. The adrenal cortex is characterized by constant cell renewal in part mediated by differentiation and lineage conversion of undifferentiated cell types. To date, the contribution of stem cells to organ plasticity during stress has been implicated but is not fully understood. Recently, we were able to show that a prolonged stress exposure leads t...

ea0073oc1.3 | Oral Communications 1: Adrenal and Cardiovascular Endocrinology | ECE2021

PDE11A4 (Phosphodiesterase 11 A4) is a modulator of the primary bilateral macronodular adrenal hyperplasia (PBMAH) phenotype: genotype/phenotype analysis of a cohort of 354 patients analysed by next-generation sequencing (NGS)

Vaduva Patricia , Anna Vaczlavik , Lucas Bouys , Neou Mario , Septier Amandine , Heurtier Victor , Cavalcante Isadora Pontes , RossellaLibe , Fabio Faucz , Gaetan Giannone , Kroiss Matthias , Borson-Chazot Francoise , Chanson Philippe , Tabarin Antoine , Marie-Christine Marie-Christine , Assié Guillaume , Candida Barisson Villares Fragoso Maria , Constantine Stratakis , Ragazzon Bruno , Bertherat Jerome

IntroductionPrimary bilateral macronodular adrenal hyperplasia (PBMAH), the most common cause of adrenal Cushing’s syndrome due to bilateral adrenal tumors, is an heterogenous disease with various clinical, hormonal and morphological characteristics. ARMC5 inactivating mutations is the most frequent genetic cause of PBMAH and variants of PDE11A4 have been associated with the disease. In order to better understand the heterogeneity ...

ea0073oc1.4 | Oral Communications 1: Adrenal and Cardiovascular Endocrinology | ECE2021

The impact of targeted treatment on echocardiographic indices in patients with overt and mild primary aldosteronism, compared to patients with essential hypertension.

Gravvanis Christos , Papanastasiou Labrini , Kaoukis Andreas , Glikofridi Spyridoula , Monastirioti Nicoleta , Voulgaris Nikolaos , Ernestini Tyfoxylou , Markou Athina , GeorgePiaditis

IntroductionPrimary aldosteronism (PA) is associated with cardiovascular events and target organ damage, such as left ventricular (LV) hypertrophy and cardiac dysfunction. However the impact of subtle aldosterone secretion on cardiac function has not yet been evaluated.AimTo prospectively evaluate the cardiac function using echocardiographic indices in patients with biochemical overt, mild PA and essential hy...

ea0073oc1.5 | Oral Communications 1: Adrenal and Cardiovascular Endocrinology | ECE2021

Primary results from MATCH: A randomised controlled trial in primary aldosteronism

Wu Xilin , Senanayake Russell , Goodchild Emily , Bashari Waiel , Salsbury Jackie , Argentesi Giulia , O’Toole Samuel , Matson Matthew , Parvanta Laila , Marker Alison , Berney Daniel , Sahdev Anju , Bird Nicholas , McConnachie Alexander , McIntosh Alasdair , Laycock Kate , Cruickshank Kennedy , Cheow Heok , Gurnell Mark , Drake William , Brown Morris

Primary aldosteronism (PA) is considered the sole, often curable, cause of hypertension in 5–10% of patients. Yet there has been only one RCT, and practice has changed little since the advent of CT scanning. Adrenal vein sampling (AVS) and adrenalectomy remain the standard, invasive interventions, leading to a 50% reduction in pill count as the average clinical improvement.Study DesignIn MATCH (Is Metomidate PET-CT superior t...

ea0073oc1.6 | Oral Communications 1: Adrenal and Cardiovascular Endocrinology | ECE2021

All-cause mortality in adrenal insufficiency patients using prednisolone or hydrocortisone replacement

Ngaosuwan Kanchana , Johnston Desmond , Godsland Ian , Cox Jeremy , Oliver Azeem , Quint Jennifer , Oliver Nick , Robinson Stephen

BackgroundWhilst hydrocortisone is standard glucocorticoid replacement therapy in patients with adrenal insufficiency, some have considered prednisolone an alternative. Some data have shown diabetes and osteoporosis risk. Mortality of patients using prednisolone in relation with those using hydrocortisone is not known. We compared all-cause mortality risk compared to matched controls in patients with primary or secondary adrenal insufficiency using predn...